Drug profile · INN
mesoridazine besylate
SERENTIL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
mesoridazine besylate (SERENTIL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN mesoridazine besylate
Brand SERENTIL
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is mesoridazine besylate?
mesoridazine besylate (SERENTIL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for mesoridazine besylate?
SERENTIL is a marketed brand name for mesoridazine besylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of mesoridazine besylate?
mesoridazine besylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.